VCIM

Velan Capital Investment Management Portfolio holdings

AUM $172M
1-Year Est. Return 385.14%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+385.14%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$106M
AUM Growth
+$6.52M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
61
New
Increased
Reduced
Closed

Top Buys

1
+$4.6M
2
+$3.95M
3
+$3.74M
4
ZOOZ
ZOOZ Strategy Ltd
ZOOZ
+$3.7M
5
NSPR icon
InspireMD
NSPR
+$3.01M

Top Sells

1
+$10.8M
2
+$8.99M
3
+$6.3M
4
ARVN icon
Arvinas
ARVN
+$3.68M
5
SCPH
scPharmaceuticals
SCPH
+$3.5M

Sector Composition

1 Healthcare 95.98%
2 Consumer Discretionary 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LQDA icon
51
Liquidia Corp
LQDA
$3.14B
– –
-239,260
NKTR icon
52
Nektar Therapeutics
NKTR
$2.08B
– –
0
NXTC icon
53
NextCure
NXTC
$43M
– –
-3,750
VRNA
54
DELISTED
Verona Pharma
VRNA
– –
-95,000
SCPH
55
DELISTED
scPharmaceuticals
SCPH
– –
-917,668
VYNE icon
56
VYNE Therapeutics
VYNE
$20.1M
– –
-30,000
ZVRA icon
57
Zevra Therapeutics
ZVRA
$561M
– –
-715,000
UPB
58
Upstream Bio Inc
UPB
$515M
– –
-107,000
FDMT icon
59
4D Molecular Therapeutics
FDMT
$424M
– –
-12,000
ARVN icon
60
Arvinas
ARVN
$788M
– –
-500,000
CATX icon
61
Perspective Therapeutics
CATX
$579M
– –
-500,000
1 2
3